Olema Pharmaceuticals, Inc. — Form D

Olema Pharmaceuticals, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-09-14. The offering totals $130.0M, of which $130.0M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (37)

Showing 25 of 37 people.

NameRoleLocation
Gorjan HrustanovicDirectorSan Diego, CA
David C Myles, Ph.D.Executive OfficerSan Francisco, CA
Sandra L Horning, M.D.DirectorSan Francisco, CA
Scott L GarlandDirectorSan Francisco, CA
Sean Bohen, M.D., Ph.D.DirectorSan Francisco, CA
Sean Bohen, M.D., Ph.D.Executive OfficerSan Francisco, CA
Andrew C RappaportDirectorSan Francisco, CA
Graham L Walmsley, M.D., Ph.D.DirectorSan Francisco, CA
Naseem C Zojwalla, M.D.Executive OfficerSan Francisco, CA
Yi C LarsonDirectorSan Francisco, CA
Cyrus L Harmon, Ph.D.DirectorSan Francisco, CA
Shane C KovacsExecutive OfficerSan Francisco, CA
Ian L ClarkDirectorSan Francisco, CA
Gorjan L Hrustanovic, Ph.D.DirectorSan Francisco, CA
Cynthia C ButittaDirectorSan Francisco, CA
Frank McCormickDirectorPALO ALTO, CA
Frank McCormickExecutive OfficerPALO ALTO, CA
Ian ClarkDirectorSOUTH SAN FRANCISCO, CA
David MylesExecutive OfficerSalt Lake City, UT
Cynthia ButittaDirectorPrinceton, NJ
Marina BozilenkoDirectorHayward, CA
Sean BohenDirectorSTEVENAGE, HERTFORDSHIRE, X0
Sean BohenExecutive OfficerSTEVENAGE, HERTFORDSHIRE, X0
Peter KushnerExecutive OfficerSan Francisco, CA
Kinney HornExecutive OfficerSan Francisco, CA

Other filings by this issuer (5)

FiledFormOfferingSold
2024-12-12D$250.0M$250.0M
2020-10-13D$87.4M$87.4M
2020-06-23D/A$55.4M$53.9M
2020-03-27D$45.0M$30.0M
2018-08-27D$6.1M$6.1M

More